Migraine is a common chronic condition characterized by recurrent attacks of severe headache with associated symptoms such as light and sound sensitivity, nausea, vomiting, and focal neurological disturbances. In 2016, migraine affected an estimated 1.04 billion people worldwide.1 Migraine prevalence and disease activity are highest among women during their childbearing years.2 Approximately 14% of people with migraine experience 5 or more attacks per month.3 For many patients, migraine episodes are debilitating, and overall, 25% of people with migraine report that they have missed a day of work or school because of migraine in the previous 3 months.3
Loder EW, Robbins MS. Monoclonal Antibodies for Migraine Prevention: Progress, but Not a Panacea. JAMA. 2018;319(19):1985–1987. doi:10.1001/jama.2018.4852
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: